Myriad Genetics Puts Up $270M For Crescendo Bioscience
Myriad Genetics Inc. announced Tuesday that it will acquire venture capital-backed Crescendo Bioscience Inc., a South San Francisco-based manufacturer of tests for inflammatory and autoimmune diseases such as rheumatoid arthritis, for...To view the full article, register now.
Already a subscriber? Click here to view full article